Nonalcoholic Fatty Liver Disease (NAFLD) and Weight Loss

From a western clinical perspective, NAFLD arises when caloric surplus, insulin resistance, and adipose tissue dysfunction drive excess fat delivery to the liver. The resulting accumulation of triglycerides and toxic lipid intermediates triggers oxidative stress, mitochondrial dysfunction, and inflammatory signaling. This pathophysiology is exceedingly common in people with overweight, obesity, or type 2 diabetes, explaining the high prevalence of NAFLD and its progressive form, NASH, in these groups. Because excess adiposity and insulin resistance are upstream causes, intentional weight loss is a cornerstone of therapy. Clinical trials and practice guidelines converge on graded benefits tied to the magnitude of weight loss. Approximately 5% loss often reduces hepatic steatosis and improves aminotransferases within weeks to a few months. When patients achieve 7–10% loss, histologic resolution of NASH becomes more likely. With sustained reductions of 10% or more, studies report regression of fibrosis in a meaningful subset over 12–24 months. Diet quality influences these outcomes: Mediterranean-style patterns with fewer refined carbohydrates and sugar-sweetened beverages decrease hepatic de novo lipogenesis and support insulin sensitivity. Exercise—both aerobic and resistance—acts as an insulin-sensitizing, liver-fat–lowering therapy even without scale changes and helps preserve lean mass during energy restriction. When lifestyle change alone does not meet targets, adjunctive therapies are considered. GLP‑1 receptor agonists produce clinically significant weight loss and have demonstrated increased NASH resolution in trials. Pioglitazone improves NASH histology, particularly in individuals with type 2 diabetes, though weight gain and other adverse effects require individualized risk–benefit assessment. In people with severe obesity, bariatric/metabolic surgery yields the largest and most durable weight loss, with high rates of NASH resolution and fibrosis improvement. Monitoring typically includes liver enzymes, noninvasive fibrosis scores (e.g., FIB‑4), and elastography to track steatosis and stiffness. Clinicians watch for risks such as gallstones with rapid weight loss and counsel on relapse prevention and long‑term maintenance.

Traditional medical systems approach fatty liver as a manifestation of whole‑person imbalance. In TCM, patterns such as phlegm‑damp accumulation and liver qi stagnation reflect impaired transformation and transport of fluids and nutrients. Treatment emphasizes restoring spleen qi and resolving dampness through dietary therapy—favoring whole foods and minimizing greasy, sweet, and highly processed items—while promoting the smooth flow of liver qi via movement and stress reduction. Ayurvedic frameworks similarly connect fatty liver to Medoroga and diminished Agni, recommending regular meal timing, mindful eating, and spices like turmeric to support digestion and metabolic balance. These traditions align with modern goals by prioritizing gradual, sustainable weight normalization. Mind–body practices—yoga, tai chi, and qigong—support adherence, improve insulin sensitivity, and reduce stress, which can otherwise perpetuate cravings and sleep disruption. Acupuncture has shown modest benefits for weight management and metabolic markers in meta‑analyses and may serve as an adjunct to lifestyle programs. Botanicals such as berberine-containing formulas, curcumin, and milk thistle have emerging human data suggesting improvements in liver enzymes and steatosis; however, product quality and study heterogeneity warrant cautious, collaborative use, especially alongside conventional medications. In practice, an integrative plan brings these perspectives together: a nutrient-dense dietary pattern compatible with Mediterranean principles and TCM/Ayurvedic dietary guidance; regular aerobic and resistance activity supplemented by yoga or tai chi; behavioral supports for sleep and stress; and, where appropriate, carefully selected pharmacotherapy or surgery. Continuous monitoring and open communication between conventional and traditional practitioners help ensure safety, manage risks like gallstones during rapid weight changes, and maintain long-term progress.